[1. L. Guo, G. Gao, X. Liu and F. Liu, Preparation and characterization of TiO2 nanosponge, Mater. Chem. Phys. 111 (2008) 322-325; DOI: 10.1186/1556-276X-6-551.10.1186/1556-276X-6-551]Search in Google Scholar
[2. D. Farrell, S. Limaye and S. Subramanian, Silicon Nanosponge Particles, U.S. Pat 0,251,561A1, 9 Nov 2006.]Search in Google Scholar
[3. V. Dakankov, M. Llyin, M. Tsyurupa, G. Timofeeva and L. Dubronina, From a dissolved polystyrene coil to intramolecularly hyper cross linked nanosponges, Macromolecules 29 (1998) 8398-8403; DOI: 10.1021/ma951673i.10.1021/ma951673i]Search in Google Scholar
[4. S. Swaminathan, L. Pastero, L. Serpe, F. Trotta, P. Vavia, D. Aquilano, M. Trotta, G. Zara and R. Cavalli, Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity, Eur. J. Pharm. Biopharm. 74 (2010) 193-201; DOI: 10.1016/ j.ejpb.2009.11.003.10.1016/j.ejpb.2009.11.003]Search in Google Scholar
[5. F. Melani, P. Mura, M. Adamo, F. Maestrelli, P. Gratteri and C. Bonaccini, New docking CFF91 parameters specific for cyclodextrin inclusion complexes, Chem. Phys. Lett. 370 (2003) 280-292; DOI: 10.1016/S0009-2614(03)00126-X.10.1016/S0009-2614(03)00126-X]Search in Google Scholar
[6. P. Couvreur and C. Vauthier, Nanotechnology: intelligent design to treat complex disease, Pharm. Res. 23 (2006) 1417-1450; DOI: 10.1007/s11095-006-0284-8.10.1007/s11095-006-0284-8]Search in Google Scholar
[7. C. Zhang, N. Awasthi, M. A. Schwarz, S. Hinz and R. E. Schwarz, Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer, PLoS One. 8 (2013) e58037; DOI: 10.1371/journal.pone.0058037.10.1371/journal.pone.0058037]Search in Google Scholar
[8. Y. Fukumori and H. Ichikawa, Nanoparticles for cancer therapy and diagnosis, Adv. PowderTechnol. 17 (2006) 1-28; DOI: 10.1163/156855206775123494.10.1163/156855206775123494]Search in Google Scholar
[9. M. Morishita and N. Peppas, Is the oral route possible for peptide and protein drug delivery, Drug Discov. Today 11 (2006) 905-910; DOI: 10.1007/s11095-006-0284-8.10.1007/s11095-006-0284-8]Search in Google Scholar
[10. H. Cohen, R. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski and G. Golomb, Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles, Gene Ther. 7 (2000) 1896-1905; DOI: 10.1038/sj.gt.3301318.10.1038/sj.gt.3301318]Search in Google Scholar
[11. L. Grislain, P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decampeneere and P. Speiser, Pharmacokinetics and distribution of a biodegradable drug-carrier, Int. J. Pharm. 15 (1983) 335-345; DOI: 10.1016/0378-5173(83)90166-7.10.1016/0378-5173(83)90166-7]Search in Google Scholar
[12. L. Illum, S. S. Davis, C. G. Wilson, N. W. Thomas, M. Frier and J. G. Hardy, Blood clearance and organ deposition of intravenously administered colloidal particles, The effects of particle size, nature and shape, Int. J. Pharm. 12 (1982) 135-146; DOI: 10.1016/0378-5173(82)90113-2.10.1016/0378-5173(82)90113-2]Search in Google Scholar
[13. P. Couvreur, B. Kante, V. Lenaerts, V. Scailteur, M. Roland and P. Speiser, Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles, J. Pharm. Sci. 69 (1980) 199-202; DOI: 10.1002/jps.2600690222.10.1002/jps.26006902227359324]Search in Google Scholar
[14. J. Kreuter, Nanoparticles, in Encyclopedia of Pharmaceutical Technology (Ed. J. Swarbrick and J. C. Boylan), Marcel Dekker In., New York 1994, pp.165-190.]Search in Google Scholar
[15. J. Xing, D. Zhang and T. Tan, Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo, Int. J. Biol. Macromol. 40 (2007) 153-158; DOI: 10.1016/j.ijbiomac.2006. 07.001.]Search in Google Scholar
[16. E. Garcia-Garcia, K. Andrieux, S. Gil and P. Couvreur, Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain, Int. J. Pharm. 298 (2005) 274-292; DOI: 10.1016/j.ijpharm.2005.03.031.10.1016/j.ijpharm.2005.03.03115896933]Search in Google Scholar
[17. S. Subramanian, A. Singireddy, K. Krishnamoorthy and M. Rajappan, Nanosponges: A Novel Class of Drug Delivery System - Review, J. Pharm. Pharmac. Sci. 15 (2012) 103-111.]Search in Google Scholar
[18. A. Nokhodchi, M. Jelvehgari, M. Reza Siahi and M. Reza Mozafar, Factors affecting the morphology of benzoyl peroxide microsponges, Micron 38 (2007) 834-840, DOI: 10.1016/j.micron. 2007.06.012.]Search in Google Scholar
[19. F. Trotta and R. Cavalli, Characterization and application of new hyper-cross-linked cyclodextrins, Compos. Interfaces 16 (2009) 39-48, DOI: 10.1163/156855408X379388.10.1163/156855408X379388]Search in Google Scholar
[20. F. Trotta, R. Cavalli, V. Tumiatti, O. Zerbinati, C. Roggero and R. Vallero, Ultrasound AssistedSynthesis of Cyclodextrin Based Nanosponges, EP Pat 1786841A1, 23May, 2007.]Search in Google Scholar
[21. S. Eki, T. Lei, L. Jingquan, J. Zhongfan, B. Cyrille and P. D. Thomas, Biodegradable star polymers functionalized with b-cyclodextrin inclusion complexes, Biomacromolecules, 10 (2009) 2699-2707; DOI: 10.1021/bm900646g.10.1021/bm900646g19663421]Search in Google Scholar
[22. S. Swaminathan, R. Cavalli, F. Trotta, P. Ferruti, E. Ranucci, I. Gerges, A. Manfredi, D. Marinotto and P. Vavia, In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem. 68 (2010) 183-191; DOI: 10.1007/s10847-010-9765-9.10.1007/s10847-010-9765-9]Search in Google Scholar
[23. A. Vyas, S. Saraf and S. Saraf, Cyclodextrin based novel drug delivery systems, J. Incl. Phenom. Macrocycl. Chem. 62 (2008) 23-42; DOI: 10.1007/s10847-008-9456-y.10.1007/s10847-008-9456-y]Search in Google Scholar
[24. T. Girek and W. Ciesielski, Polymerization of b-cyclodextrin with maleic anhydride along with thermogravimetric study of polymers, J. Incl. Phenom. Macrocycl. Chem. (2010) 1-7; DOI: 10. 1007/s10847-010-9778-4.]Search in Google Scholar
[25. D. Li and M. Ma, Nanosponges: From inclusion chemistry to water purifying technology, Chem.\ Sci. Technol. (1999) 26-28.]Search in Google Scholar
[26. C. Rajeswari, A. Alka, A. Javed and R. Khar, Cyclodextrins in drug delivery: an update review, AAPS PharmSciTech. 6 (2005) E329-E357; DOI: 10.1208/pt060243.10.1208/pt060243275054616353992]Search in Google Scholar
[27. A. Modi and P. Tayade, Comparative solubility enhancement profile of valdecoxib with different solubilization approaches, Ind. J. Pharm. Sci. 69 (2007) 427-430; DOI: 10.4103/0250-474X. 33156.]Search in Google Scholar
[28. R. Cavalli, F. Trotta and W. Tumiatti, Cyclodextrin-based nanosponges for drug delivery, J. Incl. Phenom. Macrocycl. Chem. 56 (2006) 209-213; DOI: 10.1007/s10847-006-9085-2.10.1007/s10847-006-9085-2]Search in Google Scholar
[29. F. Trotta, V. Tumiatti, R. Cavalli, C. Roggero, B. Mognetti and G. Berta, Cyclodextrin-based Nanospongesas a Vehicle for Antitumoral Drugs, WO 2009/003656 A1; 2009.]Search in Google Scholar
[30. F. Trotta and T. Wander, Cross-linked Polymers Based on Cyclodextrins for Removing PollutingAgents, WO 2003/085002, US20050154198 A1, 14 July. 2005.]Search in Google Scholar
[31. S. Swaminathan, P. Vavia, F. Trotta and S. Torne, Formulation of beta-cyclodextrin based nanosponges of Itraconazole, J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 89-94; DOI: 10.1007/s10847-006-9216-9.10.1007/s10847-006-9216-9]Search in Google Scholar
[32. A. Mele, F. Castiglione, L. Malpezzi, F. Ganazzoli, G. Raffaini, F. Trotta, B. Rossi, A. Fontana and G. Giunchi, HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in b-CD nanosponges, J. Incl. Phenom. Macrocycl. Chem. 69 (2011) 403-409; DOI: 10.1007/ s10847-010-9772-x.10.1007/s10847-010-9772-x]Search in Google Scholar
[33. S. Swaminathan, P. Vavia, F. Trotta, R. Cavalli, P. Ferruti, E. Ranucci and I. Gerges, Release modulation and conformational stabilization of a model protein by use of swellable nanosponges of b-cyclodextrin, First European Cyclodextrin Conference, Aalborg, Denmark 2009.]Search in Google Scholar
[34. S. Torne, K. Ansari, P. Vavia, F. Trotta and R. Cavalli, Enhanced oral bioavailability after administration of paclitaxel-loaded nanosponges, Drug Deliv. 17 (2010) 419-425; DOI: 10.3109/ 10717541003777233.10.3109/1071754100377723320429848]Search in Google Scholar
[35. K. Ansari, P. Vavia, F. Trotta and R. Cavalli, Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study, AAPS PharmSciTech, 12 (2011) 279-286; DOI: 10.1208/s12249-011-9584-3.10.1208/s12249-011-9584-3306634021240574]Search in Google Scholar
[36. E. Patel and R. Oswal, Nanosponge and micro sponges: a novel drug delivery system, Int. J. Res. Pharm. Chem. 2 (2012) 237-244.]Search in Google Scholar
[37. T. Loftsson and M. Brewster, Pharmaceutical applications of cyclodextrins: drug solubilization and stabilization, J. Pharm. Pharmacol. 85 (1996) 1017-1025; DOI: 10.1021/js950534b.10.1021/js950534b8897265]Search in Google Scholar
[38. A. Radi and S. Eissa, Electrochemical study of indapamide and its complexation with b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem. 71 (2011) 95-102; DOI: 10.1007/s10847-010.9906-1.10.1007/s10847-010-9906-1]Search in Google Scholar
[39. H. Bricout, F. Hapiot, A. Ponchel, E. Monflier and S. Tilloy, Chemically modified cyclodextrins: an attractive class of supramolecular hosts for the development of aqueous biphasic catalytic processes, Sustainability 1 (2009) 924-945; DOI: 10.3390/su1040924.10.3390/su1040924]Search in Google Scholar
[40. H. Dodziuk, Molecules with Holes - Cyclodextrins, in Cyclodextrins and Their Complexes (Ed. H. Dodziuk), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2006, pp. 1-30.10.1002/3527608982.ch1]Search in Google Scholar
[41. D. Li and M. Ma, Nanosponges for water purification, Clean Prod. Process. 2 (2000) 112-16; DOI: 10.1007/s100980000061.10.1007/s100980000061]Search in Google Scholar
[42. E. Bilensoy and A. Atilla, Cyclodextrin-based Nanomaterials in Pharmaceutical Field, in PharmaceuticalSciences Encyclopedia: Drug Discovery, Development, and Manufacturing, John Wiley & Sons Inc. Publishers 2010; DOI: 10.1002/9780470259818.ch31.10.1002/9780470571224.pse370]Search in Google Scholar
[43. R. Lala, A. Thorat and C. Gargote, Current trends in b-cyclodextrin based drug delivery systems, Int. J. Res. Ayur. Pharm, 2 (2011) 1520-1526.]Search in Google Scholar
[44. B. Mamba, R. Krause, T. Malefetse and S. Sithhole, Cyclodextrin nanosponges in the removal of organic matter to produce water for power generation, Water SA, 34 (2008) 657-660.10.4314/wsa.v34i5.180666]Search in Google Scholar
[45. B. Mamba, R. Krause, T. Malefetse, S. Mhlanga, S. Sithhole, K. Salipira and E. Nxumalo, Removal of geosmin and 2-methylisoborneol (2-MIB) in water from Zuikerbosch water treatment plant (Rand Water) using b-cyclodextrin polyurethane, Water SA, 32 (2007) 223-228.]Search in Google Scholar
[46. S. Tang, L. Kong, J. Ou, Y. Liu, X. Li and H. Zou, Application of cross-linked b-cyclodextrin polymer for adsorption of aromatic amino acid, J. Mol. Recogn. Macrocyclic Chem. 19 (2006) 39-48; DOI: 10.1002/jmr.756.10.1002/jmr.75616265676]Search in Google Scholar
[47. F. Trotta, R. Cavalli, S. Swaminathan, C. Sarzanini and P. Vavia, Novel functionalized nanosponges: synthesis, characterization. Safety assessment, cytotoxicity testing and interaction studies. Proceedings of the 14th International Cyclodextrin Symposium, Kyoto 2008, pp. 338-342.]Search in Google Scholar
[48. G. Yurtdas, M. Demirel and L. Genc, Inclusion complexes of fluconazole with b-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation, J. Incl. Phenom. Macrocycl. Chem. 70 (2011) 429-435; DOI: 10.1007/s10847-010-9908-z.10.1007/s10847-010-9908-z]Search in Google Scholar
[49. A. Rasheed, Cyclodextrins as drug carrier molecule: a review, Sci. Pharmac. 76 (2008) 567-598; DOI: 10.3797/scipharm.0808-05.10.3797/scipharm.0808-05]Search in Google Scholar
[50. P. Sinko, Martin’s Physical Pharmacy and Pharmaceutical Sciences, 5th ed., Lippincott Williams & Williams Publishers, Philadelphia 2006, p.466.]Search in Google Scholar
[51. T. Govender, S. Stolnik, M. Garnett, L. Illum and S. Davis, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J. Control. Release 57 (1999) 171-185; DOI: 10.1016/S0168-3659(98)00116-3.10.1016/S0168-3659(98)00116-3]Search in Google Scholar
[52. S. Galindo-Rodriguez, E. Allémann, H. Fessi and E. Doelker, Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion and nanoprecipitation methods, Pharm. Res. 21 (2004) 1428-1439; DOI: 10.1023/B:PHAM.0000036917.75634.be.10.1023/B:PHAM.0000036917.75634.be]Search in Google Scholar
[53. M. Leroueil-Le Verger, L. Fluckiger, Y. Kim, M. Hoffman and P. Maincent, Preparation and characterization of nanoparticles containing an antihypertensive agent, Eur. J. Pharm. Biopharm. 46 (1998) 137-143; DOI: 10.1016/S0939-6411(98)00015-0.10.1016/S0939-6411(98)00015-0]Search in Google Scholar
[54. N. Santos-Magalhães, H. Fessi, F. Puisieux, S. Benita and M. Seiller, An in-vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride, J. Microencapsul. 12 (1995) 195-205; DOI: 10.3109/02652049509015290.10.3109/02652049509015290]Search in Google Scholar
[55. A. Layre, R. Gref, J. Richard, D. Requier, H. Chacun, M. Appel, A. Domb and P. Couvreur, Nanoencapsulation of a crystalline drug, Int. J. Pharm. 298 (2005) 323-327; DOI: 10.1016/j. ijpharm.2005.02.039.10.1016/j.ijpharm.2005.02.039]Search in Google Scholar
[56. D. Lemoine, C. Francois, F. Kedzierewicz, V. Preat, M. Hoffman and P. Maincent, Stability study of nanoparticles of poly(b-caprolactone), poly(D,L-lactide) and poly(D,L-lactideco-glycolide), Biomaterials 17 (1996) 2191-2197. DOI: 10.1016/0142-9612(96)00049-X.10.1016/0142-9612(96)00049-X]Search in Google Scholar
[57. Y. Jeong, Y. Shim, C. Kim, G. Lim, K. Choi and C. Yoon, Effect of cryoprotectants on the reconstitution properties of surfactant-free nanoparticles of poly (D,L-lactide-co-glycolide), J. Microencapsul.22 (2005) 593-601; DOI: 10.1080/02652040500162659.10.1080/02652040500162659]Search in Google Scholar
[58. H. Redhead, S. Davis and L. Illum, Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation, J. Control. Release, 70 (2001) 353-363; DOI: 10.1016/S0168-3659(00)00367-9.10.1016/S0168-3659(00)00367-9]Search in Google Scholar
[59. M. Bivas-Benita, S. Romeijn, H. Junginger and G. Borchard, PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium, Eur. J. Pharm. Biopharm. 58 (2004) 1-6; DOI: 10.1016/j.ejpb. 2004.03.008.]Search in Google Scholar
[60. R. Pecora, Dynamic light scattering measurement of nanometer particles in liquids, J. NanoparticleRes. 2 (2000) 123-131; DOI: 10.1023/A:1010067107182.10.1023/A:1010067107182]Search in Google Scholar
[61. M. Santander-Ortega, A. Jódar-Reyes, N. Csabac, D. Bastos-González and J. Ortega-Vinuesa, Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms, J. Colloid. Interf. Sci. 302 (2006) 522-529; DOI: 10.1016/j.jcis.2006.07.031.10.1016/j.jcis.2006.07.031]Search in Google Scholar
[62. Y. Ishikawa, Y. Katoh and H. Ohshima, Colloidal stability of aqueous polymeric dispersions: effect of pH and salt concentration, Colloid Surf. B 42 (2005) 53-58; DOI: 10.1016/j.colsurfb.2005. 01.006.]Search in Google Scholar
[63. J. Shar, T. Obey and T. Cosgrove, Adsorption studies of polyether’s- Part1: Adsorption onto hydrophobic surfaces, Colloid Surf A: Physicochemical and Engineering Aspects 136 (1998) 21-33, DOI: 10.1016/S0927-7757(97)00182-9.10.1016/S0927-7757(97)00182-9]Search in Google Scholar
[64. E. Leo, B. Brina, F. Forni and M. Vandelli, In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form, Int. J. Pharm. 278 (2004) 133-141, DOI: 10. 1016/j.ijpharm.2004.03.002.10.1016/j.ijpharm.2004.03.002]Search in Google Scholar
[65. U. Bilati, E. Allemann and E. Doelker, Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles, Eur. J. Pharm. Sci. 24 (2005) 67-75; DOI: 10.1016/j.ejps.2004.09.011.10.1016/j.ejps.2004.09.011]Search in Google Scholar
[66. M. Bivas-Benita, S. Romeijn, H. Junginger and G. Borchard, PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium, Eur. J. Pharm. Biopharm. 58 (2004) 1-6; DOI: 10.1016/j.ejpb. 2004.03.008.]Search in Google Scholar
[67. H. Fessi, F. Puisieux, J. Devissaguet, N. Ammoury and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int. J. Pharm. 55 (1989) R1-R4; DOI: 10.1016/0378-5173(89)90281-0.10.1016/0378-5173(89)90281-0]Search in Google Scholar
[68. M. Chorny, I. Fishbein, H. D. Danenberg and G. Golomb, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics, J. Control. Release 83 (2002) 389-400; DOI: 10.1016/S0168-3659(02)00211-0.10.1016/S0168-3659(02)00211-0]Search in Google Scholar
[69. V. Mosqueira, P. Legrand, H. Pinto-Alphandary, F. Puisieux and G. Barratt, Poly (D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties, J. Pharm. Sci. 89 (2000) 614-626; DOI: 10.1002/(SICI) 1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7.]Search in Google Scholar
[70. J. Ren, H. Hong, J. Song and T. Ren, Particle size and distribution of biodegradable poly-D,L- -lactide-co-poly(ethylene glycol) block polymer nanoparticles prepared by nanoprecipitation, J. Appl. Polym. Sci. 98 (2005) 1884-1890; DOI: 10.1002/app.22070.10.1002/app.22070]Search in Google Scholar
[71. M. Teixeira, M. Alonso, M. Pinto and C. Barbosa, Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3methoxyxanthone, Eur. J. Pharm. Biopharm. 59 (2005) 491-500; DOI: 10.1016/j.ejpb.2004.09.002.10.1016/j.ejpb.2004.09.00215760730]Search in Google Scholar
[72. M. Tobìo, R. Gref, A. Sanchez, R. Langer and M. Alonso, Stealth PLA-PEG nanoparticles as protein carriers for nasal administration, Pharm. Res. 15 (1998) 276-279; DOI: 10.1023/A:1011922 819926.]Search in Google Scholar
[73. H. Brittain, D. Bogdanowich, J. DeVincentis, G. Lewen and A.Newman, Physical characterization of pharmaceutical solids, Pharm. Res. 8 (1991) 963-973. DOI: 10.1023/A:1015888520352.10.1023/A:1015888520352]Search in Google Scholar
[74. M. Hombreiro-Perez, J. Siepmann, C. Zinutti, A. Lamprecht, N. Ubrich, M. Hoffman, R. Bodmeier and P. Maincent, Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling, J. Control. Release 88 (2003) 413-428; DOI: 10.1016/S0168-3659(03)00030-0.10.1016/S0168-3659(03)00030-0]Search in Google Scholar
[75. M. Guyot and F. Fawaz, Nifedipine loaded-polymeric microspheres: preparation and physical characteristics, Int. J. Pharm. 175 (1998) 61-74; DOI: 10.1016/S0378-5173(98)00253-1.10.1016/S0378-5173(98)00253-1]Search in Google Scholar
[76. Y. Jeong, Y. Shim, K. Song, Y. Park, H. Ryu and J. Nah, Testosterone encapsulated surfactant-free nanoparticles of poly(D,L-lactide-co-glycolide): preparation and release behavior, Bull. KoreanChem. Soc. 23 (2002) 1579-1584.]Search in Google Scholar
[77. R. Suryanarayanan, X-Ray Powder Diffractometry, in Physical Characterization of Pharmaceutical Solids, Vol. 70 (Ed. H. G. Brittain), Marcel Dekker Inc., New York 1995, pp.187-221.10.1201/b14204-8]Search in Google Scholar
[78. J. Alongi, M. Skovi, A. Frache and F. Trotta, Novel flame retardants containing cyclodextrin nanosponges and phosphorus compounds to enhance EVA combustion properties, Polym. Degrad. Stabil. 95 (2010) 2093-2100; DOI: 10.1016/j.polymdegradstab.2010.06.030.10.1016/j.polymdegradstab.2010.06.030]Search in Google Scholar
[79. G. Gilardi, F. Trotta, R. Cavalli, P. Ferruti, E. Ranucci, G. Di Nardo, C. Roggero and V. Tumiatti, Cyclodextrin Nanosponges as Carrier for Biocatalysts, and in the Delivery and Release of Enzymes, Proteins,Vaccines and Antibodies, WO2009149883 A1, 17 Dec.2009.]Search in Google Scholar
[80. S. Renuka, B. W. Roderick and P. Kamla, Evaluation of the kinetics and mechanism of drug release from Econazole Nitrate nanosponge loaded carbopol hydrogel, Ind. J. Pharm. Edu. Res. 45 (2011) 25-31.]Search in Google Scholar
[81. S. Renuka and P. Kamla, Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation, Pharm. Dev. Technol.16 (2011) 367-376; DOI: 10.3109/10837451003739289.10.3109/1083745100373928920367024]Search in Google Scholar
[82. S. Baboota, R. Khanna, S. Agarwal, J. Ali and A. Ahuja, Cyclodextrins in Drug Delivery Systems: An update, Available from Pharma. info. net., 2003, accessed on 13/01/2011.]Search in Google Scholar
[83. V. N. Wong, G. Fernando, A. R. Wagner, J. Zhang, G. R. Kinsel, S. Zauscher and D. J. Dyer, Separation of peptides with polyionic nanosponges for MALDIMS analysis, Langmuir 25 (2009) 1459-1465; DOI: 10.1021/la802723r.10.1021/la802723r271679619123797]Search in Google Scholar
[84. A. Jenny, P. Merima, F. Alberto and T. Francesco, Role of b-cyclodextrin nanosponges in polypropylene photooxidation, Carbohyd. Polym. 86 (2011) 127-135; DOI: 10.1016/j.carbpol.2011.04. 022.]Search in Google Scholar
[85. K. William, S. Benjamin and H. Eva, Synthesis and Characterization of Nanosponges for Drug Deliveryand Cancer Treatment, www.Vanderbilt.edu, accessed on 20.12.2011.]Search in Google Scholar
[86. L. Wenting, Y. Cheng, N. Masaki, F. Gaku, M. Tadashi, M. Andrea, C. Franca, C. Fabrizio, T. Francesco and I. Yoshihisa, Cyclodextrin nanosponge-sensitized enantiodifferentiating photoisomerization of cyclooctene and 1,3-cyclooctadiene, Beilstein J. Org. Chem. 8 (2012) 1305-1311; DOI: 10.3762/bjoc.8.149. 10.3762/bjoc.8.149345875423019464]Search in Google Scholar